Metabolite Card
Formula: C2HBrClF3 (195.8902)
SMILES: FC(F)(F)C(Cl)Br
Synonyms [en]
halothane; 2,2,2-Trifluoro-1-chloro-1-bromoethane; Narcotane; 1-Bromo-1-chloro-2,2,2-trifluoroethane; 1,1,1-Trifluoro-2-bromo-2-chloroethane; 1,1,1-Trifluoro-2-chloro-2-bromoethane
Last reviewed on 2024-06-28.
Cite this Page
Halothane. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000011952). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
DBLinks
- CAS Registry Number: 151-67-7
- PubChem CID: 3562
- ChEBI: 5615
- HMDB: HMDB0015290
- LipidMaps:
- KEGG: C07515
- BioCyc:
- NCBI MeSH: Halothane
- Wikipedia: Halothane
Other DBLinks
- CAS Registry Number: 151-67-7
- PubChem: 3562
- ChEBI: ChEBI:5615
- HMDB: HMDB0015290
- KEGG: C07515
- NCBI MeSH: Halothane
- Wikipedia: Halothane
- DrugBank: DB01159
- RefMet: RM0200785
- Metlin: METLIN_3159
Class / Ontology
- WishartLab ClassyFire: [Organofluorides] Organofluorides
- RefMet: [Organofluorides] Organofluorides
- ChEBI: [CHEBI:5615] halothane
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| Reactome:R-CEL-211999 | CYP2E1 reactions |
| Reactome:R-DDI-211999 | CYP2E1 reactions |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-BTA-211981 | Xenobiotics |
| Reactome:R-CEL-211859 | Biological oxidations |
| Reactome:R-CEL-211981 | Xenobiotics |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-CFA-211999 | CYP2E1 reactions |
| Reactome:R-DRE-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-DDI-211859 | Biological oxidations |
| Reactome:R-DDI-211981 | Xenobiotics |
| Reactome:R-GGA-211999 | CYP2E1 reactions |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-211981 | Xenobiotics |
| Reactome:R-SSC-211945 | Phase I - Functionalization of compounds |
| Reactome:R-SSC-211981 | Xenobiotics |